SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-20-012440
Filing Date
2020-06-19
Accepted
2020-06-19 15:31:49
Documents
2
Period of Report
2020-06-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 1678
2 poa_schmidt.htm EX-24 7841
  Complete submission text file 0001567619-20-012440.txt   10890
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Issuer) CIK: 0001628171 (see all company filings)

IRS No.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ALLOGENE THERAPEUTICS, INC. 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
SCHMIDT ERIC THOMAS (Reporting) CIK: 0001754403 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39219 | Film No.: 20975508